Global Human Immune Globulin Intravenous Market Growth 2020-2025
According to this study, over the next five years the Human Immune Globulin Intravenous market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Human Immune Globulin Intravenous business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Human Immune Globulin Intravenous market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Human Immune Globulin Intravenous, covering the supply chain analysis, impact assessment to the Human Immune Globulin Intravenous market size growth rate in several scenarios, and the measures to be undertaken by Human Immune Globulin Intravenous companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
IVIg Liquid
IVIg Powder
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Immunodeficiency
Autoimmune Disease
Acute Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Takeda
CBPO
Grifols
Octapharma
Biotest
CSL
CNBG
Kedrion
Shanghai RAAS
Hualan Bio
LFB Group
Sichuan Yuanda Shuyang
BPL
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Human Immune Globulin Intravenous consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Immune Globulin Intravenous market by identifying its various subsegments.
Focuses on the key global Human Immune Globulin Intravenous manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Immune Globulin Intravenous with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Human Immune Globulin Intravenous submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Immune Globulin Intravenous Consumption 2015-2025
2.1.2 Human Immune Globulin Intravenous Consumption CAGR by Region
2.2 Human Immune Globulin Intravenous Segment by Type
2.2.1 IVIg Liquid
2.2.2 IVIg Powder
2.3 Human Immune Globulin Intravenous Consumption by Type
2.3.1 Global Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
2.3.2 Global Human Immune Globulin Intravenous Revenue and Market Share by Type (2015-2020)
2.3.3 Global Human Immune Globulin Intravenous Sale Price by Type (2015-2020)
2.4 Human Immune Globulin Intravenous Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.5 Human Immune Globulin Intravenous Consumption by Application
2.5.1 Global Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
2.5.2 Global Human Immune Globulin Intravenous Value and Market Share by Type (2015-2020)
2.5.3 Global Human Immune Globulin Intravenous Sale Price by Type (2015-2020)
3 Global Human Immune Globulin Intravenous by Company
3.1 Global Human Immune Globulin Intravenous Sales Market Share by Company
3.1.1 Global Human Immune Globulin Intravenous Sales by Company (2018-2020)
3.1.2 Global Human Immune Globulin Intravenous Sales Market Share by Company (2018-2020)
3.2 Global Human Immune Globulin Intravenous Revenue Market Share by Company
3.2.1 Global Human Immune Globulin Intravenous Revenue by Company (2018-2020)
3.2.2 Global Human Immune Globulin Intravenous Revenue Market Share by Company (2018-2020)
3.3 Global Human Immune Globulin Intravenous Sale Price by Company
3.4 Global Human Immune Globulin Intravenous Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Human Immune Globulin Intravenous Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Human Immune Globulin Intravenous Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Human Immune Globulin Intravenous by Regions
4.1 Human Immune Globulin Intravenous by Regions
4.2 Americas Human Immune Globulin Intravenous Consumption Growth
4.3 APAC Human Immune Globulin Intravenous Consumption Growth
4.4 Europe Human Immune Globulin Intravenous Consumption Growth
4.5 Middle East & Africa Human Immune Globulin Intravenous Consumption Growth
5 Americas
5.1 Americas Human Immune Globulin Intravenous Consumption by Countries
5.1.1 Americas Human Immune Globulin Intravenous Consumption by Countries (2015-2020)
5.1.2 Americas Human Immune Globulin Intravenous Value by Countries (2015-2020)
5.2 Americas Human Immune Globulin Intravenous Consumption by Type
5.3 Americas Human Immune Globulin Intravenous Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Immune Globulin Intravenous Consumption by Regions
6.1.1 APAC Human Immune Globulin Intravenous Consumption by Regions (2015-2020)
6.1.2 APAC Human Immune Globulin Intravenous Value by Regions (2015-2020)
6.2 APAC Human Immune Globulin Intravenous Consumption by Type
6.3 APAC Human Immune Globulin Intravenous Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Human Immune Globulin Intravenous by Countries
7.1.1 Europe Human Immune Globulin Intravenous Consumption by Countries (2015-2020)
7.1.2 Europe Human Immune Globulin Intravenous Value by Countries (2015-2020)
7.2 Europe Human Immune Globulin Intravenous Consumption by Type
7.3 Europe Human Immune Globulin Intravenous Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Human Immune Globulin Intravenous by Countries
8.1.1 Middle East & Africa Human Immune Globulin Intravenous Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Human Immune Globulin Intravenous Value by Countries (2015-2020)
8.2 Middle East & Africa Human Immune Globulin Intravenous Consumption by Type
8.3 Middle East & Africa Human Immune Globulin Intravenous Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Human Immune Globulin Intravenous Distributors
10.3 Human Immune Globulin Intravenous Customer
11 Global Human Immune Globulin Intravenous Market Forecast
11.1 Global Human Immune Globulin Intravenous Consumption Forecast (2021-2025)
11.2 Global Human Immune Globulin Intravenous Forecast by Regions
11.2.1 Global Human Immune Globulin Intravenous Forecast by Regions (2021-2025)
11.2.2 Global Human Immune Globulin Intravenous Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Human Immune Globulin Intravenous Forecast by Type
11.8 Global Human Immune Globulin Intravenous Forecast by Application
12 Key Players Analysis
12.1 Takeda
12.1.1 Company Information
12.1.2 Human Immune Globulin Intravenous Product Offered
12.1.3 Takeda Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Takeda Latest Developments
12.2 CBPO
12.2.1 Company Information
12.2.2 Human Immune Globulin Intravenous Product Offered
12.2.3 CBPO Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CBPO Latest Developments
12.3 Grifols
12.3.1 Company Information
12.3.2 Human Immune Globulin Intravenous Product Offered
12.3.3 Grifols Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Grifols Latest Developments
12.4 Octapharma
12.4.1 Company Information
12.4.2 Human Immune Globulin Intravenous Product Offered
12.4.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Octapharma Latest Developments
12.5 Biotest
12.5.1 Company Information
12.5.2 Human Immune Globulin Intravenous Product Offered
12.5.3 Biotest Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Biotest Latest Developments
12.6 CSL
12.6.1 Company Information
12.6.2 Human Immune Globulin Intravenous Product Offered
12.6.3 CSL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 CSL Latest Developments
12.7 CNBG
12.7.1 Company Information
12.7.2 Human Immune Globulin Intravenous Product Offered
12.7.3 CNBG Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 CNBG Latest Developments
12.8 Kedrion
12.8.1 Company Information
12.8.2 Human Immune Globulin Intravenous Product Offered
12.8.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Kedrion Latest Developments
12.9 Shanghai RAAS
12.9.1 Company Information
12.9.2 Human Immune Globulin Intravenous Product Offered
12.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Shanghai RAAS Latest Developments
12.10 Hualan Bio
12.10.1 Company Information
12.10.2 Human Immune Globulin Intravenous Product Offered
12.10.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Hualan Bio Latest Developments
12.11 LFB Group
12.11.1 Company Information
12.11.2 Human Immune Globulin Intravenous Product Offered
12.11.3 LFB Group Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 LFB Group Latest Developments
12.12 Sichuan Yuanda Shuyang
12.12.1 Company Information
12.12.2 Human Immune Globulin Intravenous Product Offered
12.12.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sichuan Yuanda Shuyang Latest Developments
12.13 BPL
12.13.1 Company Information
12.13.2 Human Immune Globulin Intravenous Product Offered
12.13.3 BPL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 BPL Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Human Immune Globulin Intravenous Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of IVIg Liquid
Table 5. Major Players of IVIg Powder
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
Table 8. Global Human Immune Globulin Intravenous Revenue by Type (2015-2020) ($ million)
Table 9. Global Human Immune Globulin Intravenous Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Human Immune Globulin Intravenous Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Human Immune Globulin Intravenous Consumption Market Share by Application (2015-2020)
Table 13. Global Human Immune Globulin Intravenous Value by Application (2015-2020)
Table 14. Global Human Immune Globulin Intravenous Value Market Share by Application (2015-2020)
Table 15. Global Human Immune Globulin Intravenous Sale Price by Application (2015-2020)
Table 16. Global Human Immune Globulin Intravenous Sales by Company (2017-2019) (K Units)
Table 17. Global Human Immune Globulin Intravenous Sales Market Share by Company (2017-2019)
Table 18. Global Human Immune Globulin Intravenous Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Human Immune Globulin Intravenous Revenue Market Share by Company (2017-2019)
Table 20. Global Human Immune Globulin Intravenous Sale Price by Company (2017-2019)
Table 21. Global Human Immune Globulin Intravenous Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Human Immune Globulin Intravenous Products Offered
Table 23. Human Immune Globulin Intravenous Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Human Immune Globulin Intravenous Consumption by Regions 2015-2020 (K Units)
Table 25. Global Human Immune Globulin Intravenous Consumption Market Share by Regions 2015-2020
Table 26. Global Human Immune Globulin Intravenous Value by Regions 2015-2020 ($ Millions)
Table 27. Global Human Immune Globulin Intravenous Value Market Share by Regions 2015-2020
Table 28. Americas Human Immune Globulin Intravenous Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Human Immune Globulin Intravenous Consumption Market Share by Countries (2015-2020)
Table 30. Americas Human Immune Globulin Intravenous Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Human Immune Globulin Intravenous Value Market Share by Countries (2015-2020)
Table 32. Americas Human Immune Globulin Intravenous Consumption by Type (2015-2020) (K Units)
Table 33. Americas Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
Table 34. Americas Human Immune Globulin Intravenous Consumption by Application (2015-2020) (K Units)
Table 35. Americas Human Immune Globulin Intravenous Consumption Market Share by Application (2015-2020)
Table 36. APAC Human Immune Globulin Intravenous Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Human Immune Globulin Intravenous Consumption Market Share by Regions (2015-2020)
Table 38. APAC Human Immune Globulin Intravenous Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Human Immune Globulin Intravenous Value Market Share by Regions (2015-2020)
Table 40. APAC Human Immune Globulin Intravenous Consumption by Type (2015-2020) (K Units)
Table 41. APAC Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
Table 42. APAC Human Immune Globulin Intravenous Consumption by Application (2015-2020) (K Units)
Table 43. APAC Human Immune Globulin Intravenous Consumption Market Share by Application (2015-2020)
Table 44. Europe Human Immune Globulin Intravenous Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Human Immune Globulin Intravenous Consumption Market Share by Countries (2015-2020)
Table 46. Europe Human Immune Globulin Intravenous Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Human Immune Globulin Intravenous Value Market Share by Countries (2015-2020)
Table 48. Europe Human Immune Globulin Intravenous Consumption by Type (2015-2020) (K Units)
Table 49. Europe Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
Table 50. Europe Human Immune Globulin Intravenous Consumption by Application (2015-2020) (K Units)
Table 51. Europe Human Immune Globulin Intravenous Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Human Immune Globulin Intravenous Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Human Immune Globulin Intravenous Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Human Immune Globulin Intravenous Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Human Immune Globulin Intravenous Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Human Immune Globulin Intravenous Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Human Immune Globulin Intravenous Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Human Immune Globulin Intravenous Consumption Market Share by Application (2015-2020)
Table 60. Human Immune Globulin Intravenous Distributors List
Table 61. Human Immune Globulin Intravenous Customer List
Table 62. Global Human Immune Globulin Intravenous Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Human Immune Globulin Intravenous Consumption Market Forecast by Regions
Table 64. Global Human Immune Globulin Intravenous Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Human Immune Globulin Intravenous Value Market Share Forecast by Regions
Table 66. Global Human Immune Globulin Intravenous Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Human Immune Globulin Intravenous Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Human Immune Globulin Intravenous Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Human Immune Globulin Intravenous Value Market Share Forecast by Type (2021-2025)
Table 70. Global Human Immune Globulin Intravenous Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Human Immune Globulin Intravenous Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Human Immune Globulin Intravenous Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Human Immune Globulin Intravenous Value Market Share Forecast by Application (2021-2025)
Table 74. Takeda Product Offered
Table 75. Takeda Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Takeda Main Business
Table 77. Takeda Latest Developments
Table 78. Takeda Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 79. CBPO Product Offered
Table 80. CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. CBPO Main Business
Table 82. CBPO Latest Developments
Table 83. CBPO Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 84. Grifols Product Offered
Table 85. Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Grifols Main Business
Table 87. Grifols Latest Developments
Table 88. Grifols Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 89. Octapharma Product Offered
Table 90. Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Octapharma Main Business
Table 92. Octapharma Latest Developments
Table 93. Octapharma Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 94. Biotest Product Offered
Table 95. Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Biotest Main Business
Table 97. Biotest Latest Developments
Table 98. Biotest Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 99. CSL Product Offered
Table 100. CSL Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. CSL Main Business
Table 102. CSL Latest Developments
Table 103. CSL Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 104. CNBG Product Offered
Table 105. CNBG Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 106. CNBG Main Business
Table 107. CNBG Latest Developments
Table 108. CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Kedrion Product Offered
Table 110. Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Kedrion Main Business
Table 112. Kedrion Latest Developments
Table 113. Kedrion Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 114. Shanghai RAAS Product Offered
Table 115. Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Shanghai RAAS Main Business
Table 117. Shanghai RAAS Latest Developments
Table 118. Shanghai RAAS Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 119. Hualan Bio Product Offered
Table 120. Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Hualan Bio Main Business
Table 122. Hualan Bio Latest Developments
Table 123. Hualan Bio Basic Information, Company Total Revenue (in $ million), Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
Table 124. LFB Group Product Offered
Table 125. LFB Group Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 126. LFB Group Main Business
Table 127. LFB Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. LFB Group Latest Developments
Table 129. Sichuan Yuanda Shuyang Product Offered
Table 130. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 131. Sichuan Yuanda Shuyang Main Business
Table 132. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Sichuan Yuanda Shuyang Latest Developments
Table 134. BPL Product Offered
Table 135. BPL Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 136. BPL Main Business
Table 137. BPL Latest Developments
Table 138. BPL Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Human Immune Globulin Intravenous
Figure 2. Human Immune Globulin Intravenous Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Human Immune Globulin Intravenous Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Human Immune Globulin Intravenous Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of IVIg Liquid
Figure 7. Product Picture of IVIg Powder
Figure 8. Global Human Immune Globulin Intravenous Consumption Market Share by Type (2015-2020)
Figure 9. Global Human Immune Globulin Intravenous Value Market Share by Type (2015-2020)
Figure 10. Human Immune Globulin Intravenous Consumed in Immunodeficiency
Figure 11. Global Human Immune Globulin Intravenous Market: Immunodeficiency (2015-2020) (K Units)
Figure 12. Global Human Immune Globulin Intravenous Market: Immunodeficiency (2015-2020) ($ Millions)
Figure 13. Human Immune Globulin Intravenous Consumed in Autoimmune Disease
Figure 14. Global Human Immune Globulin Intravenous Market: Autoimmune Disease (2015-2020) (K Units)
Figure 15. Global Human Immune Globulin Intravenous Market: Autoimmune Disease (2015-2020) ($ Millions)
Figure 16. Human Immune Globulin Intravenous Consumed in Acute Infection
Figure 17. Global Human Immune Globulin Intravenous Market: Acute Infection (2015-2020) (K Units)
Figure 18. Global Human Immune Globulin Intravenous Market: Acute Infection (2015-2020) ($ Millions)
Figure 19. Global Human Immune Globulin Intravenous Consumption Market Share by Application (2015-2020)
Figure 20. Global Human Immune Globulin Intravenous Value Market Share by Application (2015-2020)
Figure 21. Global Human Immune Globulin Intravenous Sales Market Share by Company in 2017
Figure 22. Global Human Immune Globulin Intravenous Sales Market Share by Company in 2019
Figure 23. Global Human Immune Globulin Intravenous Revenue Market Share by Company in 2017
Figure 24. Global Human Immune Globulin Intravenous Revenue Market Share by Company in 2019
Figure 25. Global Human Immune Globulin Intravenous Sale Price by Company in 2019
Figure 26. Global Human Immune Globulin Intravenous Consumption Market Share by Regions 2015-2020
Figure 27. Global Human Immune Globulin Intravenous Value Market Share by Regions 2015-2020
Figure 28. Americas Human Immune Globulin Intravenous Consumption 2015-2020 (K Units)
Figure 29. Americas Human Immune Globulin Intravenous Value 2015-2020 ($ Millions)
Figure 30. APAC Human Immune Globulin Intravenous Consumption 2015-2020 (K Units)
Figure 31. APAC Human Immune Globulin Intravenous Value 2015-2020 ($ Millions)
Figure 32. Europe Human Immune Globulin Intravenous Consumption 2015-2020 (K Units)
Figure 33. Europe Human Immune Globulin Intravenous Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Human Immune Globulin Intravenous Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Human Immune Globulin Intravenous Value 2015-2020 ($ Millions)
Figure 36. Americas Human Immune Globulin Intravenous Consumption Market Share by Countries in 2019
Figure 37. Americas Human Immune Globulin Intravenous Value Market Share by Countries in 2019
Figure 38. Americas Human Immune Globulin Intravenous Consumption Market Share by Type in 2019
Figure 39. Americas Human Immune Globulin Intravenous Consumption Market Share by Application in 2019
Figure 40. United States Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 41. United States Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Human Immune Globulin Intravenous Consumption Market Share by Countries in 2019
Figure 47. APAC Human Immune Globulin Intravenous Value Market Share by Regions in 2019
Figure 48. APAC Human Immune Globulin Intravenous Consumption Market Share by Type in 2019
Figure 49. APAC Human Immune Globulin Intravenous Consumption Market Share by Application in 2019
Figure 50. China Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 51. China Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 58. India Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 59. India Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Human Immune Globulin Intravenous Consumption Market Share by Countries in 2019
Figure 63. Europe Human Immune Globulin Intravenous Value Market Share by Countries in 2019
Figure 64. Europe Human Immune Globulin Intravenous Consumption Market Share by Type in 2019
Figure 65. Europe Human Immune Globulin Intravenous Consumption Market Share by Application in 2019
Figure 66. Germany Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 68. France Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 69. France Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 70. UK Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 71. UK Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Human Immune Globulin Intravenous Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Human Immune Globulin Intravenous Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Human Immune Globulin Intravenous Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Human Immune Globulin Intravenous Consumption Market Share by Application in 2019
Figure 80. Egypt Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Human Immune Globulin Intravenous Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Human Immune Globulin Intravenous Value Growth 2015-2020 ($ Millions)
Figure 90. Global Human Immune Globulin Intravenous Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Human Immune Globulin Intravenous Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 93. Americas Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 94. APAC Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 95. APAC Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 96. Europe Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 97. Europe Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 100. United States Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 101. United States Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 102. Canada Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 103. Canada Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 104. Mexico Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 105. Mexico Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 106. Brazil Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 107. Brazil Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 108. China Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 109. China Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 110. Japan Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 111. Japan Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 112. Korea Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 113. Korea Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 116. India Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 117. India Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 118. Australia Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 119. Australia Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 120. Germany Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 121. Germany Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 122. France Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 123. France Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 124. UK Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 125. UK Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 126. Italy Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 127. Italy Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 128. Russia Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 129. Russia Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 130. Spain Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 131. Spain Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 132. Egypt Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 133. Egypt Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 134. South Africa Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 135. South Africa Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 136. Israel Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 137. Israel Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 138. Turkey Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 139. Turkey Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Human Immune Globulin Intravenous Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Human Immune Globulin Intravenous Value 2021-2025 ($ Millions)
Figure 142. Takeda Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 143. CBPO Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 144. Grifols Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 145. Octapharma Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 146. Biotest Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 147. CSL Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 148. CNBG Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 149. Kedrion Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 150. Shanghai RAAS Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 151. Hualan Bio Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 152. LFB Group Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 153. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Market Share (2018-2020)
Figure 154. BPL Human Immune Globulin Intravenous Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets